`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________________
`WEST-WARD PHARMACEUTICALS
`INTERNATIONAL LIMITED
`Petitioner,
`v.
`NOVARTIS AG
`Patent Owner
`_______________________
`Case IPR2017-01078
`U.S. Patent No. 9,006,224
`_______________________
`
`
`
`
`
`
`
`
`
`PETITIONER’S UPDATED MANDATORY NOTICE
`PURSUANT TO 37 C.F.R. § 42.8(b)(1)
`
`
`
`
`
`Case IPR2017-01078
`U.S. Patent No. 9,006,224
`
`
`West-Ward Pharmaceuticals International Limited (“West-Ward”) filed an
`
`IPR Petition on March 13, 2017 (which IPR was assigned IPR2017-01078), along
`
`with a Motion for Joinder with IPR2016-01479. West-Ward was joined as a party
`
`in IPR2017-01479 on September 25, 2017. West-Ward does not have uploading
`
`status in E2E with respect to IPR2016-01479, and has been instructed by
`
`Mr. Andrew Kellogg, Supervisory Paralegal, Patent Trial and Appeal Board, to file
`
`this Updated Mandatory Notice in IPR2017-01078.
`
`West-Ward Pharmaceuticals International Limited has changed its name to
`
`Hikma Pharmaceuticals International Limited. Accordingly, pursuant to 37 C.F.R.
`
`§ 42.8(b)(1), West-Ward identifies Hikma Pharmaceuticals International Limited
`
`as a real-party-in-interest in IPR2017-01078 and IPR2016-01479.
`
`
`
`Dated: January 8, 2019
`
`
`
`
`
`Respectfully submitted,
`
`By: /Marta E. Delsignore/
`Marta E. Delsignore (Reg. No. 32,689)
`
`Counsel for Petitioner West-Ward
`Pharmaceuticals International
`Limited, now known as Hikma
`Pharmaceuticals International Limited
`
`1
`
`
`
`Case IPR2017-01078
`U.S. Patent No. 9,006,224
`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.8(b)(1), I certify that on this 8th day of January,
`
`2019, a true and correct copy of the foregoing PETITIONER’S UPDATED
`
`MANDATORY NOTICE PURSUANT TO 37 C.F.R. § 42.8(b)(1) was served
`
`by electronic mail on Patent Owner’s lead and backup counsel at the following
`
`email address:
`
`
`
`
`
`Nicholas N. Kallas (nkallas@Venable.com)
`Laura Fishwick (lfishwick@Venable.com)
`ZortressAfinitorIPR@Venable.com
`
`
`and on counsel for Argentum Pharmaceutical LLC at the following email
`
`addresses:
`
`
`
`Kevin Laurence (klaurence@lpiplaw.com)
`Matthew Phillips (mphillips@lpiplaw.com)
`Tyler C. Liu (tliu@agpharm.com)
`
`By: /Marta E. Delsignore/
`
`Marta E. Delsignore (Reg. No. 32,689)
`GOODWIN PROCTER LLP
`620 Eighth Avenue
`New York, NY 10018
`212-813-8822
`mdelsignore@goodwinprocter.com
`
`Counsel for Petitioner West-Ward
`Pharmaceuticals International
`Limited, now known as Hikma
`Pharmaceuticals International Limited
`
`
`
`